| abstract |
Formulations are provided comprising glutamic acid, or a salt thereof, and an effective amount of a peptide. The invention also provides methods of making the formulations, methods of using the formulations to treat conditions, and kits containing the components of the formulations. Further, the present invention provides a sustained-release formulation for a drug substance comprising an amount of glutamic acid, or a salt thereof, and a peptide. |